May 29, 2015 — National Security Technologies LLC (NSTec) and Henderson, Nevada-based Global Medical Isotope Systems ...
May 28, 2015 — The novel Ga-68-PSMA-ligand positron emission tomography/computed tomography (PET/CT) has substantially ...
May 27, 2015 — Ipsen announced the signature of an agreement to acquire OctreoPharm Sciences, a private German life ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
May 13, 2015 — Cancer Targeted Technology (CTT), announced that it was awarded a NIH two-year, $2 million Small Business ...
May 7, 2015 — NorthStar Medical Radioisotopes LLC has completed its first production-scale test run of the molybdenum-99 ...
May 4, 2015 — Results from Lantheus Medical Imaging Inc.’s first Phase 3 study of flurpiridaz F 18 for myocardial ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
April 30, 2015 — A first-in-human prostate cancer study in the Journal of Molecular Imaging and Biology showed initial ...
April 16, 2015 — A new four-year research study will determine the clinical usefulness and value of a brain positron ...
March 17, 2015 — NorthStar Medical Radioisotopes LLC will unveil the commercial model of its RadioGenix isotope ...
March 17, 2015 — The National Oncologic PET Registry (NOPR) Working Group submitted a formal request to the Centers for ...
March 10, 2015 — Using a mouse model of cancer, researchers at Washington University School of Medicine in St. Louis ...
March 10, 2015 — The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the ...
February 18, 2015 — Researchers at University Medical Center (UMC) Utrecht are developing an innovative cancer treatment ...
February 4, 2015 — Lantheus Medical Imaging Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ...
January 30, 2015 — The U.S. Food and Drug Administration (FDA) has approved for human evaluation a nanoparticle-based ...
January 30, 2015 — Lantheus Medical Imaging Inc. announced an agreement with the Institute for Radioelements (IRE) for ...
Nov. 13. 2014 — Coquí RadioPharmaceuticals Corp. (Coquí Pharma) is working to become the first commercial producer of ...
November 7, 2014 — Lantheus Medical Imaging Inc. and Shine Medical Technologies Inc. announced that the companies have ...
October 20, 2014 — A new analysis from the Phase III SELECT (Study of (E7080) LEnvatinib in Differentiated Cancer of the ...
October 16, 2014 — Navidea Biopharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has ...